Simplex Trading’s Albany Molecular Research Inc AMRI Stock Holding History

Simplex Trading’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-66	Closed	-$34K	–	7232
2017 Q2	$34K	Buy	66 +6	+10%	+$109	﹤0.01%	2777
2017 Q1	$1K	Sell	60 -48	-44%	-$786	﹤0.01%	6002
2016 Q4	$29K	Buy	108 +12	+13%	+$204	﹤0.01%	2715
2016 Q3	$21K	Buy	+96	New	+$1.42K	﹤0.01%	2941
2015 Q4	–	Sell	-162	Closed	-$3K	–	6647
2015 Q3	$3K	Buy	162 +106	+189%	+$2.16K	﹤0.01%	4509
2015 Q2	$11K	Buy	+56	New	+$1.08K	﹤0.01%	3023

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Simplex Trading's AMRI Position: Q3 2016 in Review

Simplex Trading sold out of Albany Molecular Research Inc (AMRI) in Q3 2016, closing a stake of 622 shares — an estimated $9.21K sold.

Simplex Trading first reported a position in AMRI in Q4 2014 and held it in 4 quarters. The position peaked at $270K in Q4 2014. 137 funds tracked by Wall St. Rank hold AMRI as of Q3 2016.

Simplex Trading reported no remaining Albany Molecular Research Inc position as of Q3 2016 after selling out during the quarter.
Simplex Trading sold 622 Albany Molecular Research Inc shares in Q3 2016, an estimated $9.21K.
Simplex Trading first reported a position in Albany Molecular Research Inc in Q4 2014 and held it in 4 quarters.
Simplex Trading's Albany Molecular Research Inc position peaked at $270K in Q4 2014.
137 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2016.

Based on Simplex Trading's 13F filing for Q3 2016, filed 7 Oct 2016.